TLDR
- Colgate Stock Jumps 4% on Strong Q4 Results and Confident 2026 Outlook
- Colgate Gains Momentum as Earnings Rise and Cash Flow Hits Record High
- Colgate Shares Rally on Solid Sales Growth and Upbeat 2026 Forecast
- Colgate Climbs After Strong Q4, Steady Growth, and Robust Cash Generation
- Colgate Advances as Q4 Beats Expectations and 2026 Guidance Signals Growth
Colgate-Palmolive (CL) shares advanced into 2026 with rising momentum as the stock traded at $88.59, up 4.10%, after a strong intraday rally. The company posted steady gains in net sales and organic sales for both the fourth quarter and the full year. Its record operating cash flow and disciplined cost controls supported a resilient performance despite weaker category trends.
Q4 Performance Strengthens as Core Categories Drive Growth
Colgate-Palmolive reported a 5.8% increase in fourth-quarter net sales as each major category contributed to higher revenue. The company lifted organic sales by 2.2%, even though lower private label pet volume created pressure. However, the firm posted a GAAP loss of $0.05 per share due to an impairment charge tied to the skin health unit.
The base business remained stable and delivered a 4% rise in earnings per share, supported by balanced pricing and volume execution. Gross profit margins declined slightly by 10 basis points, yet they stayed at 60.2% across both GAAP and base business measures. Furthermore, Colgate preserved market leadership in toothpaste with a global share of 41.3%.
The company also maintained a global market share of 32.4% in manual toothbrushes, reflecting its strong brand presence. North America posted softer results as regional sales fell 1.5%, driven by lower volumes. Even so, pricing partly offset declines and stabilized the division.
Full-Year Results Show Steady Growth and Record Cash Generation
Colgate lifted full-year net sales by 1.4% and increased organic sales by the same rate, despite a drag from pet nutrition private label. The base business delivered a 3% increase in earnings per share, supported by disciplined spending and portfolio strength. Yet GAAP earnings fell 25% due to impairment charges in the skin health business.
The company generated a record $4.2 billion in operating cash flow, which strengthened its financial flexibility. It returned $2.9 billion to shareholders through dividends and repurchases as part of its long-term capital plan. Colgate emphasized that its strategic actions over recent years expanded the business across several markets.
The impairment charge totaled $794 million after tax and reflected a lower outlook for the skin health unit. Performance in China remained weaker than expected, and softer category growth created further headwinds. Still, the company stated that operational adjustments aim to restore momentum over time.
2026 Outlook and Global Divisional Trends Support Growth Plans
Colgate expects net sales to rise between 2% and 6% in 2026 with help from foreign exchange tailwinds. The company projects organic sales growth of 1% to 4%, including a slight impact from its exit from private label pet food. Management anticipates gross profit margin expansion and earnings growth on both GAAP and non-GAAP bases.
Divisional results showed broad gains as Latin America lifted net sales by 12.8% and Africa/Eurasia advanced 15%. Europe increased sales by 9.8% as pricing and currency supported reported results across the region. Hill’s Pet Nutrition grew 4.9% and continued to contribute steady revenue despite lower private label volume.
Asia Pacific remained flat with a slight 0.3% decline, although pricing helped offset volume pressure. The company plans to drive its 2030 strategy through stronger innovation, expanded omni-channel reach, and improved digital capabilities. As 2026 begins, Colgate aims to build consistent earnings growth and reinforce long-term value creation.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
